Recent studies in MASLD and ALD models demonstrate that supplementation with NAD + precursors (e.g
To date, incretin-based approaches for obesity management appear as the most promising and rapidly developing (Supplementary Table 1), with innovations such as once-weekly (OW) injectable triple GIPR/GCGR/GLP-1R agonist retatrutide (LY3437943), cagrilintide (long-acting amylin analogue)/semaglutide 2.4 mg (CagriSema) combination, GCGR/GLP-1R dual agonists, high-dose oral semaglutide, and oral non-peptide GLP-1 receptor agonist orforglipron, with relevant implications in terms of patients compliance and environmental sustainability
The 2-Day Air threshold is a feature most peptide vendors dont offer at any price point
A sensible framework: give an acute soft-tissue course a couple of weeks before drawing conclusions, and give tendon, ligament, or nerve work considerably longer before deciding it is or is not helping
The duration of the protocol can vary wildly, from a few weeks for acute injuries to several months for chronic conditions like plantar fasciitis
We can create a personalized plan for you
